By Josh Beckerman
Cardio Diagnostics Holdings shares rose 25% after the company said the American Medical Association Current Procedural Terminology Editorial Panel is reviewing two company tests for CPT Proprietary Laboratory Analyses reimbursement codes.
The stock was recently at $2.83 and has more than doubled this year.
Cardio...
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Already a subscriber? Log In
"payment" - Google News
November 29, 2023 at 12:50AM
https://ift.tt/ls4dUN5
Cardio Diagnostics Shares Up 25% as AMA Panel Reviews Tests for Payment Codes - MarketWatch
"payment" - Google News
https://ift.tt/CcEw3qX
https://ift.tt/wQLGWDg
Bagikan Berita Ini
0 Response to "Cardio Diagnostics Shares Up 25% as AMA Panel Reviews Tests for Payment Codes - MarketWatch"
Post a Comment